Inflammation, but not skeletal muscle index, is associated with coronavirus disease 2019 mortality in patients with cancer

  • 0Nutrition and Dietetics Section, Cancer Hospital I, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.

|

|

Summary

This summary is machine-generated.

Skeletal muscle index (SMI) independently predicts in-hospital mortality in cancer patients with COVID-19. C-reactive protein (CRP) is also associated with COVID-19-related mortality in this vulnerable population.

Area Of Science

  • Oncology
  • Infectious Diseases
  • Radiology

Background

  • Patients with cancer and COVID-19 face severe disease and higher mortality risks.
  • CT-derived muscle abnormalities and inflammation are potential indicators of poor outcomes.

Purpose Of The Study

  • To assess the association between CT-derived muscle abnormalities, anthropometric parameters, inflammation, and mortality in cancer patients with COVID-19.

Main Methods

  • Retrospective study of 80 cancer patients with COVID-19 (March-December 2020).
  • Assessed weight loss, BMI, C-reactive protein (CRP), skeletal muscle index (SMI), and skeletal muscle radiodensity (SMD) via CT scans.

Main Results

  • Low SMI was linked to increased in-hospital mortality (OR: 4.81).
  • Elevated CRP correlated with COVID-19-related mortality (OR: 1.08).
  • 49% experienced weight loss >5%; 34% died from COVID-19; 15% died from cancer complications.

Conclusions

  • SMI is an independent predictor of in-hospital mortality in cancer patients with COVID-19.
  • CRP is independently associated with mortality specifically from COVID-19 infection.

Related Concept Videos

Cancer Survival Analysis 01:21

342

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Psychoneuroimmunology: Diabetes and Cancer 01:19

27

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications. 01:25

2.7K

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

• Chronic Cough: A persistent cough, often productive, is a crucial symptom of COPD.
•...

Tumor Immunotherapy 01:27

511

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies 02:49

7.6K

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Pneumonia II: Pathophysiology 01:29

253

The pathophysiology of pneumonia involves the following steps:

• Inhalation of Infectious Agents: Pneumonia typically begins when pathogenic organisms (bacteria, viruses, fungi) are inhaled or aspirated into the lower respiratory tract.


• Overcoming Lung Defenses: Ideally, the respiratory tract has defense mechanisms like mucociliary clearance and cough reflex to prevent the establishment of pathogenic organisms. If these defenses are compromised, or the pathogen is highly...